Success Metrics

Clinical Success Rate
90.0%

Based on 9 completed trials

Completion Rate
90%(9/10)
Active Trials
1(9%)
Results Posted
11%(1 trials)
Terminated
1(9%)

Phase Distribution

Ph phase_3
5
45%
Ph phase_1
4
36%
Ph phase_2
2
18%

Phase Distribution

4

Early Stage

2

Mid Stage

5

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
4(36.4%)
Phase 2Efficacy & side effects
2(18.2%)
Phase 3Large-scale testing
5(45.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

90.0%

9 of 10 finished

Non-Completion Rate

10.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

11

all time

Status Distribution
Active(1)
Completed(9)
Terminated(1)

Detailed Status

Completed9
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
1
Success Rate
90.0%
Most Advanced
Phase 3

Trials by Phase

Phase 14 (36.4%)
Phase 22 (18.2%)
Phase 35 (45.5%)

Trials by Status

completed982%
recruiting19%
terminated19%

Recent Activity

1 active trials
Showing 5 of 11
recruitingphase_3

Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults

NCT05219617
completedphase_1

Carisbamate Safety Study in Adult and Pediatric Subjects With Lennox-Gastaut Syndrome

NCT04062981
completedphase_1

Carisbamate in Adult & Pediatric Subjects With Lennox-Gastaut Syndrome

NCT03731715
completedphase_1

Bioavailability and Food Effect Study of 3 Types of Carisbamate

NCT04520360
completedphase_1

Carisbamate as a Potential Treatment for Alcohol Dependence

NCT02435381
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT05219617Phase 3

Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults

Recruiting
NCT04062981Phase 1

Carisbamate Safety Study in Adult and Pediatric Subjects With Lennox-Gastaut Syndrome

Completed
NCT03731715Phase 1

Carisbamate in Adult & Pediatric Subjects With Lennox-Gastaut Syndrome

Completed
NCT04520360Phase 1

Bioavailability and Food Effect Study of 3 Types of Carisbamate

Completed
NCT02435381Phase 1

Carisbamate as a Potential Treatment for Alcohol Dependence

Completed
NCT00492323Phase 2

An Effectiveness and Safety Study With RWJ-333369 (Carisbamate) for the Study of Postherpetic Neuralgia (PHN).

Completed
NCT00991757Phase 3

An Open-Label Extension Study to Evaluate the Safety and Tolerability of RWJ 333369 as Adjunctive Therapy in Patients 16 Years and Older With Partial Onset Seizures.

Completed
NCT00744731Phase 3

An Open-Label Extension Study of the Safety and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures

Completed
NCT00563459Phase 3

Carisbamate Retention Study (CaReS): Comparative Study on the Long Term Effectiveness, Safety and Tolerability of Carisbamate Compared to Two Other Frequently Prescribed Anti-epileptic Drugs (AEDs) in Patients With Epilepsy.

Terminated
NCT00740623Phase 3

A Study of the Effectiveness, Safety, and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures.

Completed
NCT00524056Phase 2

A Proof of Concept Study of the Effectiveness of Carisbamate in the Treatment of Essential Tremor

Completed

All 11 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
11